FDA defends increased use of guidance in new report to Congress

The FDA is defending its increased use of non-binding guidance documents rather than legally-enforceable rulemakings, arguing that guidance can better keep pace with the latest …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

FDA develops pilot to harmonize international gene therapy regulations

The FDA is setting out to streamline international regulations of gene therapies with a pilot program to review applications alongside global regulatory partners, an agency

January 12, 2024

Vertex starts gene therapy Casgevy in five patients

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, incredibly exciting

May 7, 2024

Xlife Sciences AG Publishes 2023 Annual Report – Biotech Investments

Xlife Sciences AG / Key word(s): Annual Results 23-Apr-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

April 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.